Remove 2024 Remove Asthma Remove Clinic Remove Vaccination
article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. A 2024 study published in the journal Nature Medicine found that military veterans with brain injuries saw major mental and physical improvements after just one ibogaine session.

article thumbnail

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

Sign up Learn more Addiction Alzheimers disease & dementia Arthritis & Rheumatism Attention deficit disorders Autism spectrum disorders Biomedical technology Cardiology Dentistry Diabetes Diseases, Conditions, Syndromes Endocrinology & Metabolism Gastroenterology Genetics Gerontology & Geriatrics Health Health informatics HIV & AIDS Immunology Inflammatory (..)

Provider 109
article thumbnail

Long-lasting HIV prevention shot headed toward approval

Medical Xpress

In clinical trials, no participants who received the injection acquired HIV. The long-acting shot may increase PrEP uptake, especially among those preferring injections over daily pills, but challenges remain in reaching underserved populations and ensuring equitable access.